Bioprinting Laboratories Inc.
Cleveland, OH · Biotech · Private
Genetically engineered human liver organoids (HLOs) on perfusion plates for drug hepatotoxicity testing
- Grants
- $2.6M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Pillar and perfusion well plate platforms for reproducible organoid culture from iPSC | $434,284 | |
| Federal grant | Department of Health and Human Services · Phase II · Pillar and perfusion well plate platforms for reproducible organoid culture from iPSC | $837,888 | |
| Federal grant | Department of Health and Human Services · Phase II · Pillar and perfusion well plate platforms for reproducible organoid culture from iPSC | $403,604 | |
| Federal grant | Department of Health and Human Services · Phase I · Gene-edited liver organoids for predictive hepatotoxicity | $284,638 | |
| Federal grant | Department of Health and Human Services · Phase I · Gene-edited liver organoids for predictive hepatotoxicity | $284,638 | |
| Federal grant | Department of Health and Human Services · Phase I · High-throughput DNT testing with engineered brain organoids | $306,872 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1339 | Cell-Free Bioinnovations Inc. | — | — |
| 1340 | RES GROUP, INC. | — | — |
| 1341 | DUOPHOS, LLC | — | — |
| 1342 | Bioprinting Laboratories Inc. | — | — |
| 1343 | HEPIONE THERAPEUTICS INC | — | — |
| 1344 | ARMIDA LABS, INC. | — | — |
| 1345 | Lung Biotechnology PBC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.